InterCure Ltd. (INCR.TA)
INCR.TA Stock Price Chart
Explore InterCure Ltd. interactive price chart. Choose custom timeframes to analyze INCR.TA price movements and trends.
INCR.TA Company Profile
Discover essential business fundamentals and corporate details for InterCure Ltd. (INCR.TA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
9 Sept 2007
Employees
320.00
Website
https://www.intercure.coCEO
Alexander Rabinovich
Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
INCR.TA Financial Timeline
Browse a chronological timeline of InterCure Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Earnings released on 28 Aug 2025
Earnings released on 1 May 2025
Earnings released on 13 Dec 2024
EPS came in at -ILA 0.79 , while revenue for the quarter reached ILA 56.56M .
Earnings released on 31 Aug 2024
EPS came in at -ILA 0.79 , while revenue for the quarter reached ILA 56.56M .
Earnings released on 30 Aug 2024
EPS came in at ILA 0.02 , while revenue for the quarter reached ILA 62.87M .
Earnings released on 1 May 2024
EPS came in at ILA 0.02 , while revenue for the quarter reached ILA 62.87M , missing expectations by -38.11%.
Earnings released on 31 Dec 2023
EPS came in at -ILA 0.75 , while revenue for the quarter reached ILA 73.47M .
Earnings released on 1 Sept 2023
EPS came in at ILA 0.11 surpassing the estimated ILA 0.08 by +37.50%, while revenue for the quarter reached ILA 73.47M , missing expectations by -27.67%.
Earnings released on 17 Aug 2023
EPS came in at ILA 0.11 surpassing the estimated ILA 0.08 by +42.62%, while revenue for the quarter reached ILA 102.44M , missing expectations by -7.73%.
Earnings released on 16 May 2023
EPS came in at ILA 0.01 falling short of the estimated ILA 0.08 by -87.50%, while revenue for the quarter reached ILA 106.18M , missing expectations by -4.36%.
Earnings released on 31 Dec 2022
EPS came in at ILA 0.19 , while revenue for the quarter reached ILA 105.61M .
Earnings released on 15 Nov 2022
EPS came in at ILA 0.16 falling short of the estimated ILA 0.25 by -36.00%, while revenue for the quarter reached ILA 100.57M .
Earnings released on 15 Aug 2022
EPS came in at ILA 0.34 surpassing the estimated ILA 0.18 by +88.89%, while revenue for the quarter reached ILA 95.28M , missing expectations by -10.62%.
Earnings released on 17 May 2022
EPS came in at ILA 0.36 surpassing the estimated ILA 0.18 by +100.00%, while revenue for the quarter reached ILA 87.23M .
Earnings released on 31 Dec 2021
EPS came in at -ILA 0.07 , while revenue for the quarter reached ILA 79.70M .
Earnings released on 16 Nov 2021
EPS came in at -ILA 0.03 falling short of the estimated ILA 0.15 by -120.00%, while revenue for the quarter reached ILA 61.70M .
Earnings released on 17 Aug 2021
EPS came in at ILA 0.12 falling short of the estimated ILA 0.14 by -14.29%, while revenue for the quarter reached ILA 45.23M .
Earnings released on 10 May 2021
EPS came in at ILA 0.12 , while revenue for the quarter reached ILA 33.05M .
Stock split effective on 8 Apr 2021
Shares were split 50000 : 222463 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2020
EPS came in at ILA 0.36 , while revenue for the quarter reached ILA 27.09M .
Earnings released on 30 Sept 2020
EPS came in at ILA 0.04 , while revenue for the quarter reached ILA 22.50M .
INCR.TA Stock Performance
Access detailed INCR.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.